Sethuraman Natarajan, President, Research & Develop. at Entrada Therapeutics, Inc., sold $399K of TRDA

Sethuraman Natarajan President, Research & Develop.

Entrada Therapeutics, Inc. · $TRDA

$399K Total Value

25,907 Shares Traded

$15.3939 Price / Share

216,317 Shares Owned After

2026-05-04 Filing Date

Transaction Details

Insider	Sethuraman Natarajan
Title	President, Research & Develop.
Company	Entrada Therapeutics, Inc.
Ticker	TRDA
Transaction Type	Sale
Transaction Date	2026-05-04
Shares Traded	25,907
Price Per Share	$15.3939
Total Value	$399K
Filed Date	2026-05-04
Accession Number	0001873394-26-000003

Ownership Context

Shares Owned After Transaction	216,317
Ownership Type	Direct

SEC Filing

↗ View Original SEC Filing

Accession: 0001873394-26-000003

Other Insider Trades — TRDA

Insider	Title	Action	Value	Date
PARMAR KUSH	Director, 10% Owner	traded	—	2026-06-10
Radhakrishnan Maha	Director	traded	—	2026-06-10
Thistle Mary	Director	traded	—	2026-06-10
KIM PETER S	Director	traded	—	2026-06-10
Chapman Gina	Director	traded	—	2026-06-10
Zeiher Bernhardt G	Director	traded	—	2026-06-10
Zeiher Bernhardt G	Director	bought	$29K	2026-05-20
Dowden Nathan J	President & COO	traded	$26K	2026-05-04
Dowden Nathan J	President & COO	sold	$230K	2026-05-04
WENTWORTH KORY JAMES	Chief Financial Officer	sold	$32K	2026-04-01

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for TRDA — Entrada Therapeutics, Inc. →

Track TRDA insider activity in real time on The Wire →

Get alerts when Sethuraman Natarajan files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 19, 2026 at 07:15 UTC